Work

Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma.

Year: 2016

Type: article

Source: Europe PMC (PubMed Central)

Author: Lisa A Raedler

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2341551516

FWCI: 1.79

Cites: 8

Cited by: 37

Related to: 10